Form 4: DST Capital LLC Reports Changes in Beneficial Ownership of Harvard Apparatus Regenerative Technology, Inc.

DST Capital LLC reports the transfer of warrants in Harvard Apparatus Regenerative Technology, Inc. to unaffiliated persons.

Summary

• DST Capital LLC, a 10% owner of Harvard Apparatus Regenerative Technology, Inc. (HRGN), filed a Form 4 indicating changes in beneficial ownership.
• The report details the transfer of warrants to purchase HRGN common stock to unaffiliated individuals.
• Specifically, 50,000 warrants were transferred on July 8, 2024, and an additional 25,000 and 140,000 warrants were transferred on July 31, 2024.
• These warrants have an exercise price of $2 and expire on either June 17, 2026, or September 1, 2026.
• Following these transactions, DST Capital LLC directly owns 3,725,825 shares of common stock and indirectly owns 30,722 shares.

Sentiment

Score: 5

Explanation: The document is a standard regulatory filing, indicating a neutral sentiment. It simply reports transactions without expressing any positive or negative outlook.

Industry Context

Form 4 filings are a routine part of the regulatory landscape for publicly traded companies, providing transparency into the transactions of company insiders and significant shareholders.

Stakeholder Impact

• The transfer of warrants could potentially dilute existing shareholders if the warrants are exercised in the future.

Key Dates